Triple positive tumor markers in early HCC

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|44|9|964-974

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.44, Iss.9, 2014-09, pp. : 964-974

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumor Markers in Early Diagnosis, Follow-Up and Management of Patients with Hepatocellular Carcinoma

By  

Oncology, Vol. 62, Iss. 1, 2002-01 ,pp. : 57-63

Karger

Access to resources Recommend Favorite

Early Prediction of the Outcome Using Tumor Markers and mRECIST in Unresectable Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization

By  

Oncology, Vol. 91, Iss. 6, 2016-10 ,pp. : 317-330

Karger

Access to resources Recommend Favorite

Early response to arterial chemotherapy

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 4, 2015-04 ,pp. : 726-732

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumor diameter and Ki‐67 expression in biopsy could be diagnostic markers discriminating from adenoma and early stage cancer in patients with ampullary tumors

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 20, Iss. 5, 2013-06 ,pp. : 531-537

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumor markers in an evidence-based medicine

By Bormer Ole P.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 61, Iss. 6, 2001-09 ,pp. : 417-419

Informa Healthcare

Access to resources Recommend Favorite